Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cancer after transplantation]

P Lang1, C Baron, D Cherqui

  • 1Service de néphrologie et de transplantation, hôpital Henri-Mondor, Créteil.

La Revue Du Praticien
|February 15, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting pathogen evolution and immune evasion in the age of artificial intelligence.

Computational and structural biotechnology journal·2025
Same author

Localisation of Cutaneous Disease.

Medical examiner (Philadelphia, Pa.)·2023
Same author

Initial experience with vNOTES hysterectomy for benign conditions in a French university hospital.

Facts, views & vision in ObGyn·2022
Same author

Monitoring of in-vitro ultrasonic stimulation of cells by numerical modeling.

Ultrasonics·2022
Same author

[Endometrial receptivity in assisted reproductive techniques: An aspect to investigate in embryo implantation failure].

Gynecologie, obstetrique, fertilite & senologie·2020
Same author

Efficacy and safety of rituximab in myasthenia gravis: a French multicentre real-life study.

European journal of neurology·2020

Organ transplant recipients face a higher cancer risk, primarily due to immunosuppression weakening the immune system. Close patient monitoring is crucial for early detection of virus-induced tumors and other complications post-transplant.

Area of Science:

  • Oncology
  • Immunology
  • Transplant Medicine

Background:

  • Organ transplantation necessitates immunosuppression to prevent graft rejection.
  • Immunosuppression is a known risk factor for de novo malignancies in transplant recipients.
  • Viral infections are frequently implicated in post-transplant cancers.

Purpose of the Study:

  • To highlight the increased cancer risk in transplant patients.
  • To identify immunosuppression as the primary driver of post-transplant carcinogenesis.
  • To emphasize the importance of vigilant surveillance for early complication detection.

Main Methods:

  • Review of existing literature on post-transplant malignancies.
  • Analysis of factors contributing to cancer development in immunosuppressed individuals.

Related Experiment Videos

  • Discussion of the role of viral infections in transplant-associated cancers.

    • Main Results:

    • The degree of immunosuppression, not the specific drug, is the main factor promoting cancer.
    • A significant proportion of post-transplant tumors are virus-induced.
    • Immune deficiency impairs the body's ability to fight viral infections, facilitating oncogenesis.

    Conclusions:

    • Transplant recipients require lifelong, close medical follow-up.
    • Early detection strategies are essential for managing cancer risk in this population.
    • Understanding the interplay between immunosuppression, viral infections, and cancer is critical for patient care.